Precision Oncology and Molecular Tumor Boards - Concepts, Opportunities and Challenges

被引：0
|
作者：
Holch, Julian Walter [1 ,2 ]
Westphalen, Benedikt [1 ,2 ]
Hiddemann, Wolfgang [1 ]
Heinemann, Volker [1 ,3 ]
Jung, Andreas [4 ]
Metzeler, Klaus [1 ,5 ]
机构：
[1] Klinikum Univ Munchen, Med Klin & Poliklin 3, Campus Grosshadern, Munich, Germany
[2] Comprehens Canc Ctr Munchen, Munich, Germany
[3] LMU, Krebszentrum Munchen, Comprehens Canc Ctr, Munich, Germany
[4] LMU Munchen, Pathol Inst, Munich, Germany
[5] Klinikum Univ Munchen, Lab Leukamie Diagnost, Munich, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期
关键词：
CLINICAL-TRIALS; SEQUENCE VARIANTS; MEK INHIBITION; CANCER; MEDICINE; FEASIBILITY; VALIDATION; GUIDELINES; MUTATIONS; PATHOLOGY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1676 / 1684
页数：9
相关论文
共 50 条
  • [1] Precision oncology and molecular tumor boards
    Mack, Elisabeth
    Horak, Peter
    Froehling, Stefan
    Neubauer, Andreas
    [J]. INNERE MEDIZIN, 2024, 65 (05): : 462 - 471
  • [2] Molecular Tumor Boards: Realizing Precision Oncology Therapy
    Patel, Maulik
    Kato, Shumei M.
    Kurzrock, Razelle
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 206 - 209
  • [3] Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
    Fujiwara, Yu
    Kato, Shumei
    Kurzrock, Razelle
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (02) : 197 - 216
  • [4] The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges
    Ekhator, Chukwuyem
    Kesari, Santosh
    Tadipatri, Ramya
    Fonkem, Ekokobe
    Grewal, Jai
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [5] Overview of precision oncology trials: challenges and opportunities
    Fountzilas, Elena
    Tsimberidou, Apostolia M.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (08) : 797 - 804
  • [6] MTBAct: a precision oncology maturity model towards defining best practices for molecular tumor boards
    Love, Tara
    Anaya, Daniel
    Ekinci, Okan
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S337 - S338
  • [7] Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
    Klara Dorman
    Danmei Zhang
    Kathrin Heinrich
    Laurens Reeh
    Lena Weiss
    Michael Haas
    Georg Beyer
    Daniel Rössler
    Elisabetta Goni
    Bernhard W. Renz
    Jan G. D’Haese
    Wolfgang G. Kunz
    Max Seidensticker
    Stefanie Corradini
    Maximilian Niyazi
    Steffen Ormanns
    Jörg Kumbrink
    Andreas Jung
    Frederick Klauschen
    Jens Werner
    Julia Mayerle
    Michael von Bergwelt-Baildon
    Stefan Boeck
    Volker Heinemann
    C. Benedikt Westphalen
    [J]. Targeted Oncology, 2023, 18 : 257 - 267
  • [8] Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
    Dorman, Klara
    Zhang, Danmei
    Heinrich, Kathrin
    Reeh, Laurens
    Weiss, Lena
    Haas, Michael
    Beyer, Georg
    Roessler, Daniel
    Goni, Elisabetta
    Renz, Bernhard W.
    D'Haese, Jan G.
    Kunz, Wolfgang G.
    Seidensticker, Max
    Corradini, Stefanie
    Niyazi, Maximilian
    Ormanns, Steffen
    Kumbrink, Joerg
    Jung, Andreas
    Klauschen, Frederick
    Werner, Jens
    Mayerle, Julia
    von Bergwelt-Baildon, Michael
    Boeck, Stefan
    Heinemann, Volker
    Westphalen, C. Benedikt
    [J]. TARGETED ONCOLOGY, 2023, 18 (02) : 257 - 267
  • [9] Molecular tumour boards — current and future considerations for precision oncology
    Apostolia M. Tsimberidou
    Michael Kahle
    Henry Hiep Vo
    Mehmet A. Baysal
    Amber Johnson
    Funda Meric-Bernstam
    [J]. Nature Reviews Clinical Oncology, 2023, 20 : 843 - 863
  • [10] Molecular tumour boards - current and future considerations for precision oncology
    Tsimberidou, Apostolia M.
    Kahle, Michael
    Vo, Henry Hiep
    Baysal, Mehmet A.
    Johnson, Amber
    Meric-Bernstam, Funda
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (12) : 843 - 863
12345